Widespread occurrence of bisphenol A in paper and paper products: implications for human exposure.
ABSTRACT Bisphenol A (BPA) is used in a variety of consumer products, including some paper products, particularly thermal receipt papers, for which it is used as a color developer. Nevertheless, little is known about the magnitude of BPA contamination or human exposure to BPA as a result of contact with paper and paper products. In this study, concentrations of BPA were determined in 15 types of paper products (n = 202), including thermal receipts, flyers, magazines, tickets, mailing envelopes, newspapers, food contact papers, food cartons, airplane boarding passes, luggage tags, printing papers, business cards, napkins, paper towels, and toilet paper, collected from several cities in the USA. Thermal receipt papers also were collected from Japan, Korea, and Vietnam. BPA was found in 94% of thermal receipt papers (n = 103) at concentrations ranging from below the limit of quantitation (LOQ, 1 ng/g) to 13.9 mg/g (geometric mean: 0.211 mg/g). The majority (81%) of other paper products (n = 99) contained BPA at concentrations ranging from below the LOQ to 14.4 μg/g (geometric mean: 0.016 μg/g). Whereas thermal receipt papers contained the highest concentrations of BPA (milligram-per-gram), some paper products, including napkins and toilet paper, made from recycled papers contained microgram-per-gram concentrations of BPA. Contamination during the paper recycling process is a source of BPA in paper products. Daily intake (DI) of BPA through dermal absorption was estimated based on the measured BPA concentrations and handling frequency of paper products. The daily intake of BPA (calculated from median concentrations) through dermal absorption from handling of papers was 17.5 and 1300 ng/day for the general population and occupationally exposed individuals, respectively; these values are minor compared with exposure through diet. Among paper products, thermal receipt papers contributed to the majority (>98%) of the exposures.
- SourceAvailable from: Kwang-Ho Choo[Show abstract] [Hide abstract]
ABSTRACT: The removal of bisphenol A (BPA) is important for the provision of safe drinking water, but its removal in the presence of natural organic matter (NOM) is challenging. Thus, the present study involved the fabrication and characterization of powdered activated carbons impregnated with iron oxide nanoparticles (IONPACs) with respect to the simultaneous removal of BPA and NOM. The number of Fe ions loaded into the PAC pores was optimized in terms of exposure time. Impregnation with iron oxide reduced the surface area and pore volume, but the pore size was maintained. IONPAC adsorbents had considerably greater sorption capabilities for BPA and NOM compared to native, bare PAC particles. The adsorption capacities of BPA and NOM were in the following sequence: bare PAC < hematite/PAC < magnetite/PAC < ferrihydrite/PAC. The enhanced removal by IONPACs was attributable to the surface coordination between the functional groups in the iron oxides (e.g., hydroxyl groups) and organics (e.g., phenolic/carboxyl groups). Iron oxide impregnation enabled the BPA uptake to be maintained in the presence of NOM, indicating that the hybrid adsorbent provided synergistic adsorption characteristics for BPA and NOM. Although the solution pH had a negligible impact on BPA uptake, the ionic strength showed a significant effect, particularly in the presence of divalent Ca ions.Journal of Hazardous Materials. 04/2015; 286.
- [Show abstract] [Hide abstract]
ABSTRACT: When a comprehensive report on BPA was published in 2008, few data were available to assess the extent to which known poor glucuronidation capacity impacts BPA internal dose in infants and young children. In this paper, evidence that has emerged since the 2008 report is summarized, including: 1) human biomarker studies in children aged 0–5 years; 2) animal studies of neonatal toxicokinetics; and 3) physically based pharmacokinetic (PBPK) models. To address limitations in these studies, we recommend more human biomonitoring studies in children aged 0–5 years in which unmetabolized (free) BPA and BPA metabolites are separately quantified and detailed quality-control data are reported, investigation of metabolic differences between humans and animal species used for the study of BPA metabolism, and enzyme ontogeny studies, which along with biomonitoring studies would reduce uncertainty in PBPK models of early-life BPA metabolism.Current Environmental Health Reports. 03/2014; 1(1):90-100.
- [Show abstract] [Hide abstract]
ABSTRACT: There are a large number of workers in the United States, spanning a variety of occupational industries and sectors, who are potentially exposed to chemicals that can be absorbed through the skin. Occupational skin exposures can result in numerous diseases that can adversely affect an individual's health and capacity to perform at work. In general, there are three types of chemical-skin interactions of concern: direct skin effects, immune-mediated skin effects, and systemic effects. While hundreds of chemicals (metals, epoxy and acrylic resins, rubber additives, and chemical intermediates) present in virtually every industry have been identified to cause direct and immune-mediated effects such as contact dermatitis or urticaria, less is known about the number and types of chemicals contributing to systemic effects. In an attempt to raise awareness, skin notation assignments communicate the potential for dermal absorption; however, there is a need for standardization among agencies to communicate an accurate description of occupational hazards. Studies have suggested that exposure to complex mixtures, excessive hand washing, use of hand sanitizers, high frequency of wet work, and environmental or other factors may enhance penetration and stimulate other biological responses altering the outcomes of dermal chemical exposure. Understanding the hazards of dermal exposure is essential for the proper implementation of protective measures to ensure worker safety and health.Environmental Health Insights 01/2014; 8(Suppl 1):51-62.